Literature DB >> 36264397

MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials.

Faeze Ahmadi Beni1, Mohammad Kazemi2,3, Hassan Dianat-Moghadam1, Mohadeseh Behjati4.   

Abstract

Colorectal cancer (CRC) is one of the most frequent cancers leading to death worldwide. Different signaling pathways such as the canonical Wnt signaling pathway have many effects on the development of CRC. MicroRNAs are small non-coding RNAs and different evidence represent their importance in the development of cancer via regulating the expression of their target genes. miRNAs can affect CRC progression as oncogenes or tumor suppressors. Dysregulation in miRNA expression can occur for various reasons, causes different abnormalities in the Wnt signaling pathway, and contributes to CRC development. Identifying the exact interactions between microRNAs and mRNAs or other non-coding RNAs assists in designing effective therapeutic, diagnostic, and prognostic approaches. In this review, we aim to focus on microRNAs that regulate CRC through modulating the Wnt pathway and then present the perspective outlook on the implication of miRNA in liquid biopsy for the management of patients with CRC.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cancer stem cell; Colorectal cancer; Drug resistance, Biomarker; oncomiR

Year:  2022        PMID: 36264397     DOI: 10.1007/s10142-022-00908-x

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.674


  130 in total

1.  MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.

Authors:  Sang Ba; Yi Xuan; Zi-Wen Long; Hai-Yong Chen; Shu-Sen Zheng
Journal:  Cell Physiol Biochem       Date:  2017-08-03

2.  Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

Authors:  Katia Basso; Masumichi Saito; Pavel Sumazin; Adam A Margolin; Kai Wang; Wei-Keat Lim; Yukiko Kitagawa; Christof Schneider; Mariano J Alvarez; Andrea Califano; Riccardo Dalla-Favera
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

3.  MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.

Authors:  Jia Cao; Xiu-Rui Yan; Ting Liu; Xue-Bo Han; Jing-Jing Yu; Shi-Hai Liu; Li-Bin Wang
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

Review 4.  Clinical utility of circulating non-coding RNAs - an update.

Authors:  Simone Anfossi; Anna Babayan; Klaus Pantel; George A Calin
Journal:  Nat Rev Clin Oncol       Date:  2018-09       Impact factor: 66.675

5.  Wnt/catenin β1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer.

Authors:  Yuzhuo Chen; Weiliang Song
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

Review 6.  The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.

Authors:  Emeline Bollaert; Audrey de Rocca Serra; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.261

7.  Molecular cloning of sequences from wingless, a segment polarity gene in Drosophila: the spatial distribution of a transcript in embryos.

Authors:  N E Baker
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

Review 8.  Serum microRNAs as non-invasive biomarkers for cancer.

Authors:  Jan C Brase; Daniela Wuttig; Ruprecht Kuner; Holger Sültmann
Journal:  Mol Cancer       Date:  2010-11-26       Impact factor: 27.401

9.  Human microRNA expression in sporadic and FAP-associated desmoid tumors and correlation with beta-catenin mutations.

Authors:  Aldo Cavallini; Maria Teresa Rotelli; Catia Lippolis; Domenico Piscitelli; Rosa Digennaro; Claudia Covelli; Nicola Carella; Matteo Accetturo; Donato Francesco Altomare
Journal:  Oncotarget       Date:  2017-06-27

10.  WNT5A encodes two isoforms with distinct functions in cancers.

Authors:  Matthieu Bauer; Jean Bénard; Terry Gaasterland; Karl Willert; David Cappellen
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.